DURHAM, NC / ACCESSWIRE / May 25, 2021 / Pharmacy Quality Solutions (PQS), a leading technology provider of pharmacy performance management services, and Humana (NYSE:HUM), a leading health and well-being company, announced that their 2020 innovative diabetes outcomes-based pilot program has resulted in significant improvement in measurable patient outcomes and will expand to additional pharmacies nationwide in 2021.
“Humana continues to emphasize innovation in value-based care models and to engage with pharmacists who are on the front line of patient care,” said Bethanie Stein, Humana Pharmacy Solutions President of PBM Services. “Our pilot saw a remarkable increase in patients meeting A1C goals and completing an A1C test. These results are a testament to the collaboration with pilot pharmacies and PQS. We look forward to engaging with more pharmacies and expanding their services in our diabetes outcomes program.”
Humana and PQS designed the pilot program to reward pharmacists across six states last year for improving health outcomes of Humana Medicare Advantage members with diabetes. Critical to the pilot’s success is PQS’s EQuIPP® platform, which provides pharmacists with access to patient data, including lab values and testing information, and the ability to document patient encounters. Samantha Davis, PharmD, a pharmacist at Cherokee Drug in Newport, Kentucky, said, “The EQuIPP® dashboard gave my pharmacy a more complete picture of our patients and made it easier to track patient progress and performance.”
“Seeing the innovative Humana program in EQuIPP® is evidence that value-based care is becoming a reality,” said James Kirby, Senior Director for The Kroger Co. “Community pharmacists, like those at Kroger Health, are uniquely equipped to manage the health of populations, and Humana is compensating us [pharmacists] for doing it well. We appreciate the role PQS played in creating positive partnerships between pharmacies and payers as well as their flexibility to deliver the data necessary to bring the program to life.”
PQS continues to expand its library of quality measures, going beyond adherence to include measures impacting the medical benefit. Humana will include some of these additional measures, such as Retinal Eye Exam Complete, with the program expansion.
“PQS has always recognized the power of the community pharmacy to support greater patient outcomes and has advocated for the shift in value-based reimbursement opportunities,” says Todd Sega, CEO at PQS. “With the increased awareness of community pharmacy’s potential, PQS continues to be a strong supporter for the expansion and acceleration of similar outcomes-based programs.”
About Pharmacy Quality Solutions, Inc.
Pharmacy Quality Solutions (PQS) is a healthcare quality improvement company, connecting healthcare payers and providers who value measurement as the pathway to better patient outcomes. Partners of PQS represent nearly 90% of all Medicare Part D lives and 95% of community pharmacies. PQS delivers the quality insights and guidance necessary to support their customers’ efforts to optimize the quality of medication management and use for their Medicare, Medicaid and commercial populations. PQS’s industry-leading platform EQuIPP® provides dependable measurement and reporting on key medication-use quality measures and value-based reimbursement programs focused on medication adherence, treatment outcomes and patient safety. For more information, please visit www.pharmacyquality.com.
For further information, contact David Simoneaux at 919.767.9544 or dsimoneaux@pharmacyquality.com.
Related Images
SOURCE: Pharmacy Quality Solutions, Inc.
View source version on accesswire.com:
https://www.accesswire.com/649001/Pharmacy-Quality-Solutions-and-Humana-Achieve-Noteworthy-Success-in-Diabetes-Outcomes-Pilot-Catalyzing-Program-Expansion
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…